Dr. Adam Elhofy, Ph.D., CSO, Essential Pharmaceuticals, talks about cell culture media optimization. We discussed the evolution of cell culture media optimization, current goals, and the latest strategies and tools being used.

Cell Culture Media Optimization – It’s about more than just high protein titer

The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.

Share Cell Culture Media Optimization – It’s about more than just high protein titer

Sign up to save your podcasts

Cell Culture Media Optimization – It’s about more than just high protein titer

Cell Culture Media Optimization – It’s about more than just high protein titer